Literature DB >> 14850637

Influence of the physiological blood clotting process on the coagulation of blood by staphylocoagulase.

M TAGER, A L LODGE.   

Abstract

The conversion of plasma to serum results in a variable loss of the coagulase-reacting factor (C.R.F.) of the plasma. The C.R.F. loss is incurred during the process of prothrombin conversion: conditions which favor the most effective prothrombin conversion result in maximal C.R.F. loss, while factors which interfere with prothrombin conversion spare the C.R.F. In a system containing an adequate concentration of calcium, thrombo-plastin, and prothrombin, the C.R.F. loss reflects the amount of prothrombin conversion-accelerating substances (factor V or AC globulin). If fibrin clots are produced directly by thrombin, and prothrombin conversion is excluded, there is no significant C.R.F. loss.

Entities:  

Keywords:  BLOOD COAGULATION

Mesh:

Substances:

Year:  1951        PMID: 14850637      PMCID: PMC2136096          DOI: 10.1084/jem.94.1.73

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  8 in total

1.  The role of staphylocoagulase in blood coagulation; the reaction of staphylocoagulase with coagulase-globulin to form coagulase-thrombin.

Authors:  J B MIALE
Journal:  Blood       Date:  1949-09       Impact factor: 22.113

2.  Staphylocoagulation in plasmas of various animal species.

Authors:  E B GERHEIM; J H FERGUSON
Journal:  Proc Soc Exp Biol Med       Date:  1949-06

3.  Manganous ion and activation of prothrombokinase.

Authors:  J H MILSTONE
Journal:  Proc Soc Exp Biol Med       Date:  1951-01

4.  Relationship of coagulase-globulin to prothrombin.

Authors:  J B MIALE
Journal:  Proc Soc Exp Biol Med       Date:  1950-11

5.  Staphylococcal coagulase; the nature of plasma activator in the clotting process.

Authors:  E S DUTHIE; L LORENZ
Journal:  Nature       Date:  1950-05-06       Impact factor: 49.962

6.  The Influence of certain Bacteria on the Coagulation of the Blood.

Authors:  L Loeb
Journal:  J Med Res       Date:  1903-12

7.  Prothrombin consumption, serum prothrombic activity and prothrombin conversion accelerator in hemophilia and thrombocytopenia.

Authors:  B ALEXANDER; G LANDWEHR
Journal:  J Clin Invest       Date:  1949-11       Impact factor: 14.808

8.  The immunochemistry of toxins and toxoids; the crystallization and characterization of tetanol toxin.

Authors:  L PILLEMER; R G WITTLER
Journal:  J Exp Med       Date:  1948-08       Impact factor: 14.307

  8 in total
  4 in total

1.  Enzymatic activity of staphylocoagulase. II. Dissociation of plasma clotting from tributyrinase activity.

Authors:  M C DRUMMOND; M TAGER
Journal:  J Bacteriol       Date:  1959-09       Impact factor: 3.490

2.  Interaction of an alkali stable polysaccharide from cell surface of Staphylococci with human fibrinogen.

Authors:  K Yoshida; T Ohtomo; Y Usui
Journal:  Experientia       Date:  1978-07-15

3.  The comparative action of dicumarol and of phenylindanedione on the coagulase reacting factor and on prothrombin.

Authors:  M TAGER
Journal:  Yale J Biol Med       Date:  1953-04

4.  Complete genome of Staphylococcus aureus Tager 104 provides evidence of its relation to modern systemic hospital-acquired strains.

Authors:  Richard W Davis; Andrew D Brannen; Mohammad J Hossain; Scott Monsma; Paul E Bock; Matthias Nahrendorf; David Mead; Michael Lodes; Mark R Liles; Peter Panizzi
Journal:  BMC Genomics       Date:  2016-03-03       Impact factor: 3.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.